| Financial Year |
March 31 2023 |
| Monetary Funds |
584,972,093.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
23,503,624.02 |
| Accounts Receivable |
350,135,369.40 |
| Advances to Suppliers |
16,318,717.28 |
| Other Receivables |
29,916,145.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
378,811,100.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
107,701,790.91 |
| Total Current Assets |
1,491,358,841.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
356,295,068.65 |
| Investment Properties |
32,111,182.57 |
| Fixed Assetes |
573,128,800.52 |
| Under-construction Projects |
1,542,766,824.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,171,762,499.90 |
| R&D expenses |
1,503,175,539.16 |
| Goodwill |
413,584,000.09 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
97,200,582.90 |
| Other Non-Current Assets |
1,371,910.00 |
| Sub-Total of Non-Current Assets |
6,487,690,739.39 |
| Total Assets |
7,979,049,580.53 |
| Short-Term Loans |
323,305,001.11 |
| Trading Financial liabilities |
10,000,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
467,601,302.68 |
| Accounts Received In Advance |
1,960,047.07 |
| Employee Compensation Payable |
86,169,666.42 |
| Taxes Payable |
18,278,465.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
202,795,020.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,565,178.31 |
| Other Current Liabilities |
221,987.03 |
| Sub-Total of Current Liabilities |
1,123,650,323.49 |
| Long-term Loans |
1,676,030,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
69,630,799.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,857,226,153.34 |
| Total Liabilities |
2,980,876,476.83 |
| Paid-In Capital(Or Share Stock) |
417,467,045.00 |
| Capital Surplus |
2,149,681,115.49 |
| Surplus Reserve |
209,437,194.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,025,807,827.71 |
| Minority Stockholder's Interest |
104,451,588.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,893,721,514.96 |
| Owner's Equity（Stockholder's Equity） |
4,998,173,103.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,979,049,580.53 |
